No results.

HTDK Debuts at the 2026 China Medical Equipment Conference: Empowering Clinical Practice with a Global Vision and Accelerating Localization of Innovative Products

29 Mar 2026

The 2026 China Medical Equipment Conference and Exhibition recently concluded in Chongqing. As a flagship event for China’s medical equipment sector, the conference gathered top research institutes, medical institutions, and industry leaders to explore the future of innovation in the field.

HTDK, a leading commercialization platform dedicated to global innovative medical devices, showcased three of its core flagship products. The exhibition highlighted HTDK’s strategic layout in respiratory diagnostics and minimally invasive surgery, as well as its robust capabilities in commercial transformation.

Redefining Pulmonary Function Testing: PulmOne MiniBox+ (Israel)

To address the clinical pain points of early screening and long-term management of respiratory diseases, HTDK presented the MiniBox+ from PulmOne, Israel.

  • Technical Breakthrough: This device breaks the traditional reliance on large, enclosed plethysmograph cabins. Utilizing advanced AI algorithms, it achieves full pulmonary function testing—including Spirometry, Total Lung Capacity (TLC), Diffusing Capacity of the Lungs for Carbon Monoxide (DLCO), and Bronchodilator Challenges—within a compact, desktop-sized unit.
  • Clinical Value: It significantly improves patient comfort and, due to its small footprint and ease of operation, is ideal for respiratory departments, health check-up centers, and thoracic surgery units. It effectively supports the decentralization of high-quality medical resources.

A "Crystal Clear" Vision for High-End Surgery: FAROMED Endoscopic Defogging System (Germany)

In the field of minimally invasive surgery, HTDK introduced the FAROMED Endoscopic Defogging System, imported directly from Germany.

  • Full-Scenario Compatibility: Designed specifically for 4K Ultra-HD, fluorescence endoscopy, 3D endoscopy, and Da Vinci robotic surgical systems.
  • Intelligent Efficiency: Featuring fully automated defogging, the system rapidly eliminates interference from surgical mist and stains. A new integrated display allows surgical teams to monitor device status in real-time, ensuring precision and fluidity during complex procedures.

     

From "Technology Import" to "Local Iteration": HTDK’s Proprietary "Ginching" System

The debut of HTDK’s self-owned brand, “Ginching” (暻清), garnered significant attention as a milestone in the company’s deepening localization strategy.

  • German Heritage, Local Optimization: In 2025, HTDK introduced core German heating and defogging technology to China. The product underwent a full-process localization upgrade to better align with the operational habits and equipment compatibility of Chinese hospitals.
  • The “Ginching” Philosophy: The name “Ginching” signifies “Brightness” (Jing) and “Purity” (Qing). The system achieves ultra-fast defogging within 10 seconds and features an automatic temperature control system to strictly prevent thermal injury risks.
  • Service Advantage: Leveraging local production, Ginching offers competitive delivery speeds and immediate after-sales response, combining European Standards with China Speed.

Looking Ahead: Bridging the "Last Mile" of Innovation

This conference served as more than just a product showcase; it was a catalyst for the integration of industry, academia, research, and medicine. Looking forward, HTDK will continue to deepen its involvement in the transformation of global innovative technologies.

Through its “Import + Localization” dual-drive model, HTDK aims to bridge the “last mile” of translating innovative achievements into clinical practice, providing high-value solutions for Chinese healthcare institutions. As medical equipment moves toward a future of intelligence, precision, and minimally invasive procedures, HTDK remains at the forefront of clinical needs, contributing to the high-quality development of China’s medical device industry.